Lingao Ju

3.2k total citations
70 papers, 1.6k citations indexed

About

Lingao Ju is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lingao Ju has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 27 papers in Cancer Research and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lingao Ju's work include Bladder and Urothelial Cancer Treatments (20 papers), Ferroptosis and cancer prognosis (18 papers) and Epigenetics and DNA Methylation (18 papers). Lingao Ju is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Ferroptosis and cancer prognosis (18 papers) and Epigenetics and DNA Methylation (18 papers). Lingao Ju collaborates with scholars based in China, United States and Japan. Lingao Ju's co-authors include Yu Xiao, Xinghuan Wang, Gang Wang, Kaiyu Qian, Min Wu, Yejinpeng Wang, Xuefeng Liu, Yongwen Luo, Lianyun Li and Yi Zhang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Lingao Ju

67 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingao Ju China 24 1.0k 537 430 285 265 70 1.6k
Hongqing Xi China 24 763 0.7× 561 1.0× 631 1.5× 416 1.5× 543 2.0× 81 1.9k
Yi-Qing Qu China 23 951 0.9× 562 1.0× 459 1.1× 89 0.3× 209 0.8× 69 1.4k
Funeng Jiang China 25 954 0.9× 564 1.1× 330 0.8× 113 0.4× 280 1.1× 65 1.5k
Wenlong Zhai China 18 765 0.7× 450 0.8× 162 0.4× 216 0.8× 224 0.8× 59 1.2k
Hiroyuki Achiwa Japan 15 605 0.6× 329 0.6× 312 0.7× 173 0.6× 659 2.5× 28 1.7k
Zherui Wu China 18 749 0.7× 365 0.7× 161 0.4× 91 0.3× 395 1.5× 26 1.4k
Claudio Pulito Italy 21 785 0.8× 525 1.0× 286 0.7× 115 0.4× 312 1.2× 36 1.3k
Xiangjin Zheng China 21 1.2k 1.1× 609 1.1× 252 0.6× 78 0.3× 257 1.0× 27 1.7k
Yidong Yang China 18 635 0.6× 483 0.9× 342 0.8× 145 0.5× 126 0.5× 45 1.2k
Matthew K. Howe United States 8 524 0.5× 490 0.9× 129 0.3× 350 1.2× 229 0.9× 8 1.0k

Countries citing papers authored by Lingao Ju

Since Specialization
Citations

This map shows the geographic impact of Lingao Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingao Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingao Ju more than expected).

Fields of papers citing papers by Lingao Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingao Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingao Ju. The network helps show where Lingao Ju may publish in the future.

Co-authorship network of co-authors of Lingao Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Lingao Ju. A scholar is included among the top collaborators of Lingao Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingao Ju. Lingao Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Kangping, Siming Chen, Huimin Xu, et al.. (2025). RNF112 Facilitates Ubiquitin‐Mediated Degradation of c‐Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer. Advanced Science. 12(20). e2408311–e2408311.
2.
Wang, Gang, Zhilong Li, Lingao Ju, et al.. (2024). Causal association of smoking, blood lipids, and bladder cancer: Insights from a multivariable and mediation mendelian randomization investigation. Journal of Cancer. 15(7). 1929–1939. 1 indexed citations
3.
Liu, Jianmin, Yongwen Luo, Siming Chen, et al.. (2024). Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT. Advanced Science. 11(45). e2403995–e2403995. 11 indexed citations
4.
Xiao, Yu, Wan Jin, Lingao Ju, et al.. (2024). Tracking single-cell evolution using clock-like chromatin accessibility loci. Nature Biotechnology. 43(5). 784–798. 13 indexed citations
5.
Li, Mingxing, Lingao Ju, Yejinpeng Wang, et al.. (2024). USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death and Disease. 15(1). 44–44. 35 indexed citations
6.
Zhou, Fenfang, Zhao Deng, Mengxin Lü, et al.. (2024). DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11. Oncogene. 43(8). 594–607. 11 indexed citations
7.
Xiao, Yu, Lingao Ju, Jin Wan, et al.. (2024). Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis. Clinical and Translational Medicine. 15(1). e70153–e70153. 1 indexed citations
8.
Wang, Tingjun, Gang Wang, Fenfang Zhou, et al.. (2024). ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway. Journal of Cancer. 15(11). 3297–3312. 1 indexed citations
9.
Li, Mingxing, Lingao Ju, Fenfang Zhou, et al.. (2023). TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC. Oncogene. 43(7). 470–483. 10 indexed citations
10.
Liu, Wei, Lingao Ju, Wan Jin, et al.. (2022). MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3. Oncogene. 41(41). 4606–4617. 31 indexed citations
11.
Zhou, Fenfang, Zhao Deng, Kaiyu Qian, et al.. (2021). The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma. Cancer Cell International. 21(1). 257–257. 12 indexed citations
12.
Chen, Siming, Zhiwen He, Fenfang Zhou, et al.. (2021). PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability. JCI Insight. 6(19). 9 indexed citations
13.
Xu, Huimin, Lingao Ju, Yaoyi Xiong, et al.. (2021). E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell Death and Disease. 12(3). 239–239. 41 indexed citations
14.
Xiong, Kangping, Gang Wang, Fenfang Zhou, et al.. (2021). The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer. Cancer Cell International. 21(1). 461–461. 8 indexed citations
15.
Wang, Gang, Songtao Cheng, Yaoyi Xiong, et al.. (2020). The role and function of PPARγ in bladder cancer. Journal of Cancer. 11(13). 3965–3975. 20 indexed citations
16.
Wang, Gang, Rui Cao, Kaiyu Qian, et al.. (2020). <p>TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 8825–8835. 16 indexed citations
17.
Cheng, Songtao, Xiaolu Zhu, Fenfang Zhou, et al.. (2020). BORA regulates cell proliferation and migration in bladder cancer. Cancer Cell International. 20(1). 290–290. 5 indexed citations
18.
Li, Qinglan, Lingao Ju, Jie Yao, et al.. (2019). The hyper-activation of transcriptional enhancers in breast cancer. Clinical Epigenetics. 11(1). 48–48. 47 indexed citations
19.
Ju, Lingao, et al.. (2018). Characterization of WDR20: A new regulator of the ERAD machinery. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(7). 970–980. 4 indexed citations
20.
Wang, Xiang, Lingao Ju, Jiadong Fan, et al.. (2014). Histone H3K4 methyltransferase Mll1 regulates protein glycosylation and tunicamycin-induced apoptosis through transcriptional regulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(11). 2592–2602. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongqing Xi Breakdown of academic impact, for papers by Yi-Qing Qu Breakdown of academic impact, for papers by Funeng Jiang Breakdown of academic impact, for papers by Wenlong Zhai Breakdown of academic impact, for papers by Hiroyuki Achiwa Breakdown of academic impact, for papers by Zherui Wu Breakdown of academic impact, for papers by Claudio Pulito Breakdown of academic impact, for papers by Xiangjin Zheng Breakdown of academic impact, for papers by Yidong Yang Breakdown of academic impact, for papers by Matthew K. Howe
Rankless by CCL
2026